|
Volumn 17, Issue 6, 2002, Pages 409-412
|
Central nervous system prophylaxis with high-dose methotrexate does not give rise to significant electroencephalographic changes in children with acute lymphoblastic leukemia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ASPARAGINASE;
ASPARAGINASE MEDAC;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
FOLINIC ACID;
MERCAPTOPURINE;
METHOTREXATE;
PREDNISONE;
VINCRISTINE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADOLESCENT;
ARTICLE;
CANCER RECURRENCE;
CANCER RISK;
CENTRAL NERVOUS SYSTEM TUMOR;
CHILD;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
COHORT ANALYSIS;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG INFUSION;
DRUG MEGADOSE;
ELECTROENCEPHALOGRAPHY;
FEMALE;
GERMANY;
HUMAN;
MALE;
MALIGNANT NEOPLASTIC DISEASE;
MEDICAL EXAMINATION;
MEDICAL SOCIETY;
NEUROLOGIC DISEASE;
PATIENT MONITORING;
PRIORITY JOURNAL;
PROPHYLAXIS;
QUANTITATIVE ANALYSIS;
SYMPTOM;
ADOLESCENT;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ASPARAGINASE;
BRAIN;
CENTRAL NERVOUS SYSTEM NEOPLASMS;
CHILD;
CHILD, PRESCHOOL;
ELECTROENCEPHALOGRAPHY;
FEMALE;
HUMANS;
INFANT;
INJECTIONS, INTRAVENOUS;
INJECTIONS, SPINAL;
LEUCOVORIN;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L1;
MALE;
METHOTREXATE;
|
EID: 0036592811
PISSN: 08830738
EISSN: None
Source Type: Journal
DOI: 10.1177/088307380201700602 Document Type: Article |
Times cited : (8)
|
References (18)
|